NCT05199584 2026-03-05A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsEndeavor Biomedicines, Inc.Phase 2 Completed20 enrolled
NCT04284774 2025-12-04Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment TrialNational Cancer Institute (NCI)Phase 2 Active not recruiting5 enrolled 9 charts
NCT04081701 2025-11-21DOMINO-STARTWeill Medical College of Cornell UniversityPhase 4 Recruiting200 enrolled
NCT03583528 2025-06-13DOTATOC PET/CT for Imaging NET PatientsBritish Columbia Cancer AgencyActive not recruiting800 enrolled